146 related articles for article (PubMed ID: 18473825)
1. Gastrin-releasing peptide receptors regulate proliferation of C6 Glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism.
Flores DG; de Farias CB; Leites J; de Oliveira MS; Lima RC; Tamajusuku AS; Di Leone LP; Meurer L; Brunetto AL; Schwartsmann G; Lenz G; Roesler R
Curr Neurovasc Res; 2008 May; 5(2):99-105. PubMed ID: 18473825
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
3. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway.
Clarimundo VS; Farinon M; Pedó RT; Teixeira VON; Nör C; Gulko PS; Xavier RM; de Oliveira PG
Peptides; 2017 Sep; 95():57-61. PubMed ID: 28733141
[TBL] [Abstract][Full Text] [Related]
5. Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.
Wen X; Chao C; Ives K; Hellmich MR
BMC Mol Biol; 2011 Jul; 12():29. PubMed ID: 21745389
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells.
Ishola TA; Kang J; Qiao J; Evers BM; Chung DH
Biochim Biophys Acta; 2007 Jun; 1770(6):927-32. PubMed ID: 17379415
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase is required for bombesin-induced enhancement of fear memory consolidation in the hippocampus.
Roesler R; Valvassori SS; Castro AA; Luft T; Schwartsmann G; Quevedo J
Peptides; 2009 Jun; 30(6):1192-6. PubMed ID: 19463755
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
Kiaris H; Schally AV; Sun B; Armatis P; Groot K
Oncogene; 1999 Nov; 18(50):7168-73. PubMed ID: 10597318
[TBL] [Abstract][Full Text] [Related]
9. BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.
Schmidt AL; de Farias CB; Abujamra AL; Kapczinski F; Schwartsmann G; Brunetto AL; Roesler R
J Mol Neurosci; 2010 Mar; 40(3):303-10. PubMed ID: 19642024
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095).
Sotomayor S; Muñoz-Moreno L; Carmena MJ; Schally AV; Sánchez-Chapado M; Prieto JC; Bajo AM
Int J Cancer; 2010 Oct; 127(8):1813-22. PubMed ID: 20099275
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice.
Matsumoto Y; Yokoi H; Kimura T; Matsumoto Y; Kawada M; Arae K; Nakae S; Ikeda T; Matsumoto K; Sakurai H; Saito K
Laryngoscope; 2018 Nov; 128(11):E377-E384. PubMed ID: 30151920
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of bombesin/gastrin-releasing peptide decrease the expression of angiogenic and anti-apoptotic factors in human glioblastoma.
Kanashiro CA; Schally AV; Cai RZ; Halmos G
Anticancer Drugs; 2005 Feb; 16(2):159-65. PubMed ID: 15655413
[TBL] [Abstract][Full Text] [Related]
14. Spinal Functions of B-Type Natriuretic Peptide, Gastrin-Releasing Peptide, and Their Cognate Receptors for Regulating Itch in Mice.
Kiguchi N; Sukhtankar DD; Ding H; Tanaka K; Kishioka S; Peters CM; Ko MC
J Pharmacol Exp Ther; 2016 Mar; 356(3):596-603. PubMed ID: 26669425
[TBL] [Abstract][Full Text] [Related]
15. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway.
Sharif TR; Luo W; Sharif M
Mol Cell Endocrinol; 1997 Jun; 130(1-2):119-30. PubMed ID: 9220028
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.
Chatzistamou I; Schally AV; Szepeshazi K; Groot K; Hebert F; Arencibia JM
Cancer Lett; 2001 Sep; 171(1):37-45. PubMed ID: 11485826
[TBL] [Abstract][Full Text] [Related]
19. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
[TBL] [Abstract][Full Text] [Related]
20. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
